Recruiting at 1 site No phase Cardiovascular Syndrome, Metabolic

Clinical trial for Cardiovascular Syndrome, Metabolic

Official title High-Intensity Interval Training(HIIT) on Cardio-metabolic Risk in School-age Children

ClinicalTrials.gov ID: NCT06416488

What this study is testing

What it's testing
The study wants to see if HIIT improves health and whether kids will keep doing it over time.
Who it's for
School‑age children who are at high risk for cardiovascular disease.
What's involved
Participants will take part in a HIIT exercise program, with visits and tests to track changes.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 7 to 18

You may be able to join if

  • Aged 7-18 years at baseline.
  • Prediabetes (Impaired fasting glucose: 5.6 ≤ fasting blood glucose level ≤ 6.9 mmol/L
  • Lipid abnormalities (High-density lipoprotein cholesterol ≤ 1.04 mmol/L; or Low-density lipoprotein cholesterol ≥ 3.37 mmol/L
  • Elevated blood pressure (Systolic/diastolic blood pressure consistently higher than the 90th percentile for gender, age, and height
  • Written consent from participants and their guardians.

You likely can't join if

  • Previously diagnosed with heart failure, severe malnutrition, immune deficiency, liver or kidney disease, cancer, or other diseases deemed unsuitable...
  • Taking weight loss drugs, or undergone weight loss surgery.
  • Attending behavior-based intervention programs (exercise or diet) within a year.
  • Regular HIIT (at least once per week).
  • Secondary obesity, such as neuropsychiatric disorders, endocrine disorders, sleep apnea syndrome, or other conditions.
  • Unable to take interventions due to health conditions, such as joint diseases, fractures, injuries.
See the full eligibility criteria
Who can join
  • Aged 7-18 years at baseline.
  • Prediabetes (Impaired fasting glucose: 5.6 ≤ fasting blood glucose level ≤ 6.9 mmol/L; or Impaired glucose tolerance: 7.8 ≤ blood glucose level after 2 hours postprandial ≤ 11.0 mmol/L).
  • Lipid abnormalities (High-density lipoprotein cholesterol ≤ 1.04 mmol/L; or Low-density lipoprotein cholesterol ≥ 3.37 mmol/L; or Triglycerides ≥ 1.70 mmol/L, or Total cholesterol ≥ 5.18 mmol/L).
  • Elevated blood pressure (Systolic/diastolic blood pressure consistently higher than the 90th percentile for gender, age, and height; or systolic/diastolic blood pressure ≥ 120/80 mmHg).
  • Written consent from participants and their guardians.
What rules you out
  • Previously diagnosed with heart failure, severe malnutrition, immune deficiency, liver or kidney disease, cancer, or other diseases deemed unsuitable for participation.
  • Taking weight loss drugs, or undergone weight loss surgery.
  • Attending behavior-based intervention programs (exercise or diet) within a year.
  • Regular HIIT (at least once per week).
  • Secondary obesity, such as neuropsychiatric disorders, endocrine disorders, sleep apnea syndrome, or other conditions.
  • Unable to take interventions due to health conditions, such as joint diseases, fractures, injuries.
  • Other situations unsuitable for participation.

The study team makes the final eligibility decision.

Where it is enrolling

  • Shanghai, Shanghai Municipality, China

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 7 years to 18 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.